Cargando…

Paraneoplastic neurological syndromes associated with ovarian tumors

INTRODUCTION: Paraneoplastic neurological syndromes (PNS) are neurologic deficits triggered by an underlying remote tumor. PNS can antedate clinical manifestation of ovarian malignancy and enable its diagnosis at an early stage. Interestingly, neoplasms associated with PNS are less advanced and meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaborowski, Mikolaj Piotr, Spaczynski, Marek, Nowak-Markwitz, Ewa, Michalak, Slawomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Review – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282879/ https://www.ncbi.nlm.nih.gov/pubmed/24965744 http://dx.doi.org/10.1007/s00432-014-1745-9

Ejemplares similares

Cell-Mediated Immune Responses in Paraneoplastic Neurological Syndromes
por: Zaborowski, Mikolaj Piotr, et al.
Publicado: (2013)

Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy
por: Zaborowski, Mikołaj Piotr, et al.
Publicado: (2020)

Is peripheral paraneoplastic neurological syndrome possible in primary brain tumors?
por: Koszewicz, Magdalena, et al.
Publicado: (2016)

The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood–brain barrier breakdown in patients with paraneoplastic neurological syndromes
por: Michalak, Slawomir, et al.
Publicado: (2018)

Choriocarcinoma complicated with intra-abdominal and intrapleural hemorrhage in pregnancy – case report
por: Jaz, Kamila, et al.
Publicado: (2023)

Ovarian Teratoma-Related Paraneoplastic Neurological Syndromes
por: Lin, Jingfang, et al.
Publicado: (2022)

Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab
por: Kuk, Anna, et al.
Publicado: (2017)

TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
por: Szajnik, Marta, et al.
Publicado: (2009)

Expression of the MT1 Melatonin Receptor in Ovarian Cancer Cells
por: Jablonska, Karolina, et al.
Publicado: (2014)

Successful pregnancy after conservative management of early stage endometrial carcinoma in a young nulliparous woman
por: Magnowska, Magdalena, et al.
Publicado: (2015)

Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival
por: Halon, Agnieszka, et al.
Publicado: (2011)

Guillain-Barré Syndrome as a Presenting Symptom in Breast Cancer: The Importance of Considering Paraneoplastic Neurologic Syndrome
por: Madala, Samragnyi, et al.
Publicado: (2021)

Vulvar melanoma with urethral invasion and bladder metastases – a case report and review of the literature
por: Lemańska, Agnieszka, et al.
Publicado: (2015)

Paraneoplastic neurological syndromes
por: Honnorat, Jérôme, et al.
Publicado: (2007)

Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis
por: Iżycka, Natalia, et al.
Publicado: (2023)

Antisynthetase Syndrome With Paraneoplastic Antibodies
por: Pokharel, Ashbina, et al.
Publicado: (2023)

Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes
por: Bastiaansen, Anna E M, et al.
Publicado: (2021)

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
por: Chiu, Daniel, et al.
Publicado: (2023)

Serum Proteomic Profiles of Patients with High and Low Risk of Endometrial Cancer Recurrence
por: Pietkiewicz, Dagmara, et al.
Publicado: (2023)

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes
por: van Coevorden‐Hameete, Marleen H., et al.
Publicado: (2017)

MALDI-MSI—A Step Forward in Overcoming the Diagnostic Challenges in Ovarian Tumors
por: Pietkiewicz, Dagmara, et al.
Publicado: (2020)

Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review
por: Li, Lin, et al.
Publicado: (2022)

The use of eye‐movement recording in patients with anti‐Hu antibody–associated paraneoplastic neurological syndromes to objectively determine extent and course of disease
por: Janssen, Malou, et al.
Publicado: (2021)

Immunotherapy in Ovarian Cancer
por: Siminiak, Natalia, et al.
Publicado: (2022)

Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome
por: Michalak, S, et al.
Publicado: (2009)

Paraneoplastic neurologic syndrome: A practical approach
por: Kannoth, Sudheeran
Publicado: (2012)

Paraneoplastic neurological syndromes: clinical presentations and management
por: Devine, Michelle F., et al.
Publicado: (2021)

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021)

Chemokine expression in patients with ovarian cancer or benign ovarian tumors
por: Nowak, Marek, et al.
Publicado: (2021)

Usefulness of the HE4 biomarker as a second-line test in the assessment of suspicious ovarian tumors
por: Moszynski, Rafal, et al.
Publicado: (2013)

Paraneoplastic Neurological Disorders
por: Newsom-Davis, John
Publicado: (1999)

Paraneoplastic Neurologic Disorders
por: Gilligan, Michael, et al.
Publicado: (2023)

Serum Tumor Markers in Paraneoplastic Neurologic Syndromes: A Systematic Review of Guidelines
por: Trevisiol, Chiara, et al.
Publicado: (2021)

Minimal-change disease as a paraneoplastic syndrome in a patient with ovarian carcinoma
por: González-Fontal, Guido R., et al.
Publicado: (2011)

The Pulmonary Complications of Paraneoplastic Autoimmune Vasculitis in a Patient With Myelodysplastic Syndrome
por: Jagadish, Pooja S, et al.
Publicado: (2020)

Breast Cancer Presents with a Paraneoplastic Neurologic Syndrome
por: Barata, Pedro Coelho, et al.
Publicado: (2012)

Paraneoplastic Neurologic Syndromes in Children: A Review Article
por: ALAVI, Samin
Publicado: (2013)

Diagnostic Approach to a Patient With Paraneoplastic Neurological Syndrome
por: Mahta, Ali, et al.
Publicado: (2012)

Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome
por: Sun, Xuan, et al.
Publicado: (2020)

Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
por: Hébert, Julien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_74hro1lsktg58lbkkcrg16s0b5